Volcanoes are erupting in The Philippines, but on-fire Australia received some welcome rain. The Iran war cries have been called off and The Donald’s military powers are about to be hamstrung by the Senate. Meanwhile, his impeachment trial is starting, and we’re all on Twitter for a front-row seat.
A new report released Monday charts a path for the transition out of the Covid-19 pandemic, one that outlines both how the country can deal with the challenge of endemic Covid disease and how to prepare for future biosecurity threats.
Her blood type, B positive, wasn’t a match for many donor organs, and a mismatched transplant would be catastrophic and deadly. But new research suggests this barrier could disappear if donor organs were treated with special enzymes that make them compatible with recipients of any blood type.
About a year ago, Matthew Kunzman’s heart was failing, despite doctors’ best attempts to bolster it with every pump and gadget they could think of. But the 14-year-old has bounced back in large part due to super-speedy genetic sequencing that pinpointed the cause of his disease and helped doctors decide how to treat it — in just 11 and a half hours.
Saying bold steps are needed to improve racial, ethnic, and gender diversity in science, the influential Howard Hughes Medical Institute on Thursday announced a $2 billion plan to accelerate inclusion and equity efforts throughout the academic science pipeline.
The announcement that a pill from Merck and partner Ridgeback Biotherapeutics kept Covid patients out of the hospital made headlines and moved stocks late last week. But as is so often true when data are released by press release, there are still many questions left unanswered.
Well over a year into the Covid-19 pandemic, visualizations of case data have become ubiquitous. By far, the most popular metric that public health officials and media outlets rely on is the daily count of new cases.